Home LiteratureArticle Details

PMID: 3121465 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.

Haematologica ·Vol. 72 ·No. 5 ·1987-00-00 ·Pages 431-7

Bandini G, Baccarani M, Cavazzini G, Battista R, Leoni F, Morra E, Comotti B, Scapoli G, Todeschini G, Mangoni L

Abstract

暂无摘要

MeSH Terms

Adolescent Adult Antineoplastic Combined Chemotherapy Protocols/therapeutic use Child Clinical Trials as Topic Cytarabine/administration & dosage Daunorubicin/administration & dosage Etoposide/administration & dosage Female Humans Leukemia/drug therapy Male Middle Aged Thioguanine/administration & dosage Vindesine/administration & dosage

Chemicals

Cytarabine Etoposide Thioguanine Vindesine Daunorubicin

Authors & Affiliations

10 authors, click to expand affiliations / ORCID

Bandini G

Baccarani M

Cavazzini G

Battista R

Leoni F

Morra E

Comotti B

Scapoli G

Todeschini G

Mangoni L

Supplementary Concepts

DAT protocol 1 (Protocol)

Article Info

Journal

Haematologica

Abbr.

Haematologica

ISSN

0390-6078

Published

1987-00-00

Pages

431-7

Language

English

Region

Italy

NLM ID

0417435

Subset

External Links

PubMed source View journal details

Analysis Services

Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.

Contact

WeChat Official Account